BDBM261879 9-Ethyl-3-[1-methyl-5-(1H-1,2,3-triazol-1-yl)-1H-benzimidazole-2-yl]-9H-carbazole::US9708311, 128
SMILES CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C)-n1ccnn1
InChI Key InChIKey=ZSEFHZBAIXQASL-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 261879
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Bayer Pharma Aktiengesellschaft
US Patent
Bayer Pharma Aktiengesellschaft
US Patent
Affinity DataIC50: 111nMT: 2°CAssay Description:4 μl of a cAMP-d2/cell suspension (625000 cells/ml) were added to a test plate containing the substance solutions already initially introduced (...More data for this Ligand-Target Pair